Key Takeaways

• Effective dosing depends on injury severity, body composition, and metabolic rate. One-size-fits-all protocols don’t account for how differently your body clears peptides.
• Pharmaceutical-grade sourcing is non-negotiable. Gray-market vials often contain underdosed or contaminated compounds that won’t deliver therapeutic results.
• Subcutaneous administration using 27–30 gauge insulin syringes is standard. Localized injections near the injury site can amplify repair signals.
• Baseline assessment of inflammatory markers and tissue health establishes whether you’re starting from acute damage or chronic degeneration.
• Injecting within a few centimeters of damaged tissue—rotator cuff tear, patellar tendon strain—can enhance localized recovery.
• Bacteriostatic water for reconstitution and sterile injection technique are basic safety requirements.
• Without baseline data, you can’t distinguish actual peptide effects from placebo or natural recovery.

Quick Summary

Getting the Wolverine stack dosage right requires more than following a forum protocol. The difference between actual tissue repair and wasted injections comes down to dosing aligned with your injury type and individual metabolic response. Most protocols assume uniform clearance rates across all users, but your inflammatory baseline and body composition shift how BPC-157 and TB-500 behave in your system.

What You Need Before Starting

You need a baseline. Understanding your current inflammatory state and tissue damage helps determine your starting point. A clinical evaluation distinguishes acute inflammation from chronic tissue breakdown. Without this diagnostic checkpoint, you’re guessing whether symptom improvement reflects structural repair or temporary pain suppression.

Sourcing matters. Verified, high-purity compounds ensure your biological response isn’t compromised by contaminants or inaccurate concentrations. We’ve seen clients run full protocols on underdosed vials and wonder why recovery stalled.

The practical setup is straightforward: fine-gauge insulin syringes, bacteriostatic water, sterile vials, and alcohol swabs. Subcutaneous administration is standard for both peptides, though localized injections near the injury can support site-specific repair. If you’re targeting a patellar tendon strain, injecting near the joint may help. But systemic healing still occurs with standard subcutaneous dosing, so don’t force localized injections if you’re not comfortable with the technique.

Timeline for Personalized Dosing

Most people expect a fixed 4–6 week cycle. Adaptive dosing extends that. You’ll start with a loading phase (typically 250–500 mcg of BPC-157 daily, paired with 2–5 mg of TB-500 twice weekly), then adjust based on your response and clinical progress. If inflammation resolves quickly within 10 days, you may taper BPC-157 to maintenance dosing earlier. If symptoms persist, you’ll extend the loading phase another week. The entire protocol usually spans 8–12 weeks, with follow-up evaluation at 30 and 60 days to confirm collagen remodeling is progressing.

The difficulty level is intermediate. You need comfort with self-injection, monitoring your body’s response, and adjusting doses based on clinical guidance. This isn’t set-it-and-forget-it. If you’re not willing to track progress systematically, stick to fixed-dose protocols—though you’ll sacrifice the precision that separates mediocre results from full recovery.

Time investment includes twice-weekly injections, regular progress monitoring during the loading phase, and at least one mid-cycle consult with a provider who understands peptide pharmacokinetics. If you’re used to tracking macros or HRV, the learning curve is manageable. If you’ve never worked with a structured recovery protocol, budget extra time to learn the mechanics.

Why Dosing Precision Matters

Getting the Wolverine stack dosage dialed in isn’t about following a protocol sheet. It’s about understanding what these peptides actually do for tissue repair and why precision matters. We see clients expecting overnight cartilage regrowth or tendon strength after a single vial, only to realize that tailored dosing aligned with their injury type and metabolic response is what separates real recovery from temporary symptom relief.

Peptide pharmacokinetics vary significantly between individuals. A compound with a four-hour half-life in one person may clear faster in someone with higher renal filtration or slower in someone with compromised liver function. Cookie-cutter protocols assume uniform metabolism across all users. When you account for these variables, you can time injections to maintain stable serum levels throughout the repair window, maximizing receptor engagement without creating tolerance.

Why Generic Protocols Miss

Most online protocols assume a standard adult weight with moderate injury severity. That’s fine if you fit that profile exactly. But body composition, injury chronicity, and metabolic rate all shift peptide clearance rates. A 90-kilogram athlete with a fresh hamstring tear needs a different loading phase than a 55-kilogram runner with chronic Achilles tendinopathy.

Injection timing also matters more than most protocols acknowledge. Research on tissue repair peptides shows peak activity occurs two to six hours post-administration, meaning your training or physical therapy window should align with that curve. If you’re injecting at night and doing rehab in the morning, you’re missing the window where collagen synthesis rates are elevated. Strategic timing turns the same dose into better results.

When This Stack Isn’t Worth It

Skip the Wolverine stack for minor muscle soreness or routine training fatigue. These peptides are built for structural injury: tendons, ligaments, partial tears. Not general recovery. If you can train through the discomfort without compensation patterns, you’re better off with sleep optimization and protein timing. The evidence for peptide intervention in non-structural issues isn’t compelling, and the cost adds up.

Also consider your competitive status if you’re subject to WADA or NCAA guidelines. Both compounds are banned for athletic competition. Anyone subject to random testing should account for these restrictions regardless of whether an injury is legitimate. The stack is generally suited to longevity-focused clients and recreational athletes who want faster recovery without competitive restrictions.

What Happens When You Get It Right

When the dosage aligns with your injury profile, you typically notice early pain reduction and functional improvements by week three. This reflects collagen density increasing and inflammatory markers dropping. The goal isn’t just symptom relief—it’s restoring structural integrity and range of motion so you can load the tissue progressively without re-injury risk.

Prerequisites

Before you calculate your dosage, you need three things: a baseline biomarker panel, reconstitution supplies, and a clear injury assessment. Jumping straight to injection protocols without understanding your starting inflammatory state or tissue damage severity makes it impossible to adjust dosing intelligently. Accurate dosing requires mapping your body’s current state.

What Biomarkers You Should Measure First

You need a snapshot of your current tissue health and inflammatory load before starting the stack. Baseline inflammatory markers (CRP, IL-6) and muscle breakdown indicators (creatine kinase) can help gauge your system’s starting point. High inflammatory readings tell you your system is already in overdrive, which may require adjustments to initial doses to manage systemic inflammation before localized repair can take priority.

Genetic cancer risk markers matter more than most sources acknowledge. Both peptides promote angiogenesis—new blood vessel formation—which accelerates healing but also carries theoretical risk if you have undiagnosed malignancies or high-risk genetic variants. Consulting with a qualified healthcare provider about personal cancer risk before initiating the stack is necessary because compounds that stimulate blood vessel growth in someone with active or latent cancer could theoretically support tumor vascularization. No standard dosing chart accounts for this.

Metabolic rate and body composition data also shape your dosing schedule. Someone with higher lean muscle mass and a faster metabolic rate will clear peptides from their system more quickly, which may require more frequent injections or adjusted doses per administration. Analyzing your lean tissue volume allows you to calibrate the stack to match your specific metabolic clearance rate.

Reconstitution and Storage Tools

Both peptides arrive as lyophilized powder and require reconstitution with bacteriostatic water before injection. You’ll need bacteriostatic water (0.9% benzyl alcohol), sterile vials, ultra-fine insulin needles (typically 1 mL capacity with 27–30 gauge), and alcohol swabs. Skip the bacteriostatic water and use sterile water instead, and your peptides degrade faster. Bacteriostatic formulations extend shelf life to 28 days in the refrigerator once reconstituted.

Store reconstituted vials at 2–8°C (refrigerator temperature, not freezer). We’ve had clients freeze their peptides thinking it would preserve potency longer, but freeze-thaw cycles denature the peptide structure and reduce bioavailability. Keep unopened lyophilized powder in the freezer if you’re not using it immediately, but once you add bacteriostatic water, it stays in the fridge and gets used within a month.

Injury Assessment and Classification

Your injury type determines which peptide takes priority in the stack and how you sequence doses. Acute soft tissue injuries—fresh muscle tears, ligament sprains—respond well to front-loaded BPC-157 because collagen synthesis and blood vessel formation at the immediate injury site drive early recovery. Chronic tendinopathy or systemic joint inflammation benefits more from TB-500’s cell migration and widespread inflammatory reduction.

Injury severity and timeline matter. Acute localized damage (less than two weeks old), subacute recovery (two to eight weeks), and chronic degeneration (ongoing for months) each respond differently. Acute cases typically benefit from higher localized doses near the injury site with moderate systemic support. Chronic cases may require stronger systemic TB-500 to calm baseline inflammation, with lower BPC-157 dosing to support gradual tissue remodeling.

Tracking biomarker data, injury classification, and body composition allows for recalibration based on follow-up inflammatory markers and subjective recovery feedback. That’s the foundation of responsive peptide therapy: dynamic dosing that responds to how your tissue actually heals.

How the Stack Works

The Wolverine stack dosage you choose depends on understanding how two distinct peptides—BPC-157 and TB-500—work together in your system. BPC-157 focuses on localized tissue repair by accelerating blood vessel formation and collagen synthesis at the injury site. TB-500 operates systemically, promoting cell migration and reducing inflammation throughout your body. When you combine them, you’re addressing both the immediate damage and the broader inflammatory response that slows recovery.

We see confusion around dosing because most generic protocols ignore individual metabolic variables. Your body weight, injury severity, and baseline inflammatory state all shift how these peptides behave. A localized ligament sprain in the ankle requires a different therapeutic focus than widespread joint wear in the shoulder. The key is matching your dose to your injury architecture—whether you’re dealing with acute structural damage or lingering inflammation from overuse.

How BPC-157 Targets Tissue Architecture

BPC-157 is a synthetic pentadecapeptide derived from a protective gastric protein. It’s stable in gastric acid, which technically allows oral administration, but we recommend subcutaneous injection for musculoskeletal injuries because you need the peptide concentrated at the injury site. The mechanism centers on microvascular expansion, which delivers oxygen and nutrients to damaged tissue faster than your baseline repair process.

Typical daily dosing ranges from 250–500 mcg, injected near the injury or systemically depending on whether you’re treating a localized problem or systemic inflammation. The peptide also upregulates growth factor receptors in damaged tissue, which means your body becomes more responsive to its own repair signals. This is why BPC-157 works best when combined with adequate protein intake and sleep—you’re amplifying your existing recovery machinery, not replacing it.

How TB-500 Handles Systemic Inflammation

TB-500 is a synthetic version of Thymosin Beta-4, a peptide your body naturally produces during injury. It promotes cell migration to the injury site and reduces inflammatory cytokines that would otherwise prolong the healing timeline. Unlike BPC-157, which you inject near the injury, TB-500 works systemically and distributes throughout your body after injection.

Standard TB-500 dosing starts with a loading phase (typically 5 mg twice weekly for 2–4 weeks) to saturate your system, followed by a maintenance phase (2–3 mg weekly). This maintenance phase keeps that concentration stable without overloading your body’s peptide clearance pathways. Tracking inflammatory markers during the loading phase can help confirm the peptide is reducing baseline inflammation, not just masking symptoms.

Why Route of Administration Changes Outcomes

Since BPC-157 remains stable in gastric acid, you could theoretically dose it orally for gut-focused healing conditions like inflammatory bowel disease. But for musculoskeletal injuries, subcutaneous or intramuscular injection delivers the peptide directly to the tissue that needs repair. Oral dosing distributes the peptide systemically before it reaches the injury site, which dilutes its effectiveness for localized damage.

TB-500 always requires injection because it’s degraded in the digestive system. The choice between subcutaneous and intramuscular injection comes down to injury location. For joint or tendon injuries, subcutaneous injection near the site maximizes local concentration. For systemic inflammation or diffuse muscle damage, intramuscular injection in a large muscle group distributes the peptide more evenly.

Step-by-Step Implementation

We build personalized peptide protocols by starting with your baseline health assessment and wellness goals. Most generic protocols give you a fixed injection schedule and hope for the best. Our approach uses comprehensive consultations and personalized wellness protocols to support your recovery—because what works for acute tissue damage won’t match what you need for chronic health optimization.

Calculating Your Starting Dose

Your initial dose depends on three variables: health goals, body composition, and individual response patterns. For moderate soft tissue support, we begin with conservative dosing (250 mcg BPC-157 daily, 2.5 mg TB-500 twice weekly) and adjust based on your consultation and ongoing assessment. If your health history suggests elevated inflammation, we tailor the protocol to target systemic wellness first. For localized concerns like tissue recovery, we may recommend site-specific administration to support healing at the area of concern.

Body composition matters, but not in the linear way most protocols assume. Lean body mass is a more useful reference than total weight—your muscle tissue concentration influences uptake more than your overall scale number. Two clients at the same weight can require noticeably different starting doses if one carries more lean mass.

Metabolic rate shifts how quickly peptides process through your system. If you have a faster metabolism (higher resting heart rate, active thyroid function), you may benefit from more frequent dosing to maintain consistent support. We monitor this through follow-up consultations and adjust timing accordingly. Some clients start on daily protocols and move to every-other-day once we observe stable progress.

Setting Up Your Injection Schedule

Your injection frequency should match your recovery timeline and personal tolerance for daily protocols. Acute injuries—fresh tissue strains, new damage—respond better to daily injections for the first two weeks because you’re addressing the initial healing window before scar tissue forms. Chronic issues tolerate 2–3 injections per week since you’re supporting long-term tissue remodeling rather than immediate repair.

Cycling protocols in phases helps maintain effectiveness over time. Higher-frequency protocols (daily injections) typically use shorter active periods to avoid adaptation. Daily injection clients often run four-week cycles followed by rest periods. Lower-frequency schedules (three times per week) can extend to six-week cycles with longer breaks. This inverse relationship between frequency and cycle length helps preserve responsiveness and prevents the plateau most clients experience when running the same protocol indefinitely.

Track your subjective wellness and functional capacity weekly. A simple rating scale for discomfort at rest, discomfort under activity, and movement quality helps guide adjustments. If progress stalls by week two, we revisit your protocol and consider modest dose increases or frequency changes. The goal is to find the minimum effective dose that supports your recovery.

Adjusting Based on Real-Time Response

Your protocol evolves based on how you respond during consultations and self-reported progress. We check in at regular intervals to assess whether systemic wellness markers are improving. If subjective feedback improves but functional limitations persist, the issue is usually localized—so we adjust administration sites or protocol composition. If overall wellness plateaus, we evaluate whether the approach needs modification or extended support.

Follow-up assessments help us determine whether tissue health is actually improving. Objective measures like range of motion, strength tests, or imaging (when available through your own healthcare providers) can show whether structural repair is occurring or if symptoms are simply being masked. We’ve seen clients feel better subjectively while function shows no structural change—that’s a signal to refine the protocol before returning to full activity. When progress is confirmed, we taper dosing gradually and extend rest intervals to allow natural repair processes to complete.

Best Practices

We adjust peptide protocols based on response signals that generic guides often overlook: recovery velocity markers, injection site tolerance patterns, and systemic inflammatory shifts. IGF-1 levels can indicate whether peptides are driving actual tissue remodeling or just circulating without effect. When IGF-1 stays elevated beyond the active cycle, that signals receptor saturation—extending your off period prevents desensitization and keeps the protocol effective for future use.

Tracking Whether Your Dosage Is Working

Your body gives clear signals when the dosage aligns with your tissue repair needs. CRP and procollagen markers at the two-week mark can show whether inflammation is dropping and collagen synthesis is accelerating. If CRP hasn’t budged after 14 days, the dose may be too conservative or the injury severity may demand a different approach—continuing the same protocol wastes time and peptides. Real recovery shows up as measurable shifts in these markers, not vague “feeling better” reports.

Injection site reactions also reveal dosing mistakes. Persistent redness or swelling at the injection site means you’re either injecting too frequently in the same area or using a concentration that exceeds local tissue tolerance. Rotating injection sites within a 2-inch radius around the injury and avoiding the exact same spot within 48 hours prevents localized irritation and ensures peptide absorption remains consistent.

Common Mistakes That Kill Progress

Stopping the protocol too early because pain improves. Subjective relief often occurs long before structural integrity is restored. If you stop at 10 days because your tendon feels fine, you’re leaving the repair half-finished. The tissue hasn’t regained its full load-bearing capacity yet, and re-injury risk stays high. Running the full protocol even when symptoms resolve, then tapering rather than stopping abruptly, supports complete tissue repair.

Another pitfall is chasing higher doses when progress stalls. If recovery plateaus at week three, adding more peptide volume rarely fixes it. The bottleneck is usually systemic—inadequate protein intake, poor sleep quality, or ongoing mechanical stress on the injury. Addressing those variables before adjusting dosage is necessary. Your body can only rebuild tissue as fast as your recovery environment allows.

Optimizing Cycle Timing for Long-Term Use

If you’re running multiple cycles for chronic injuries, the off period matters as much as the active phase. A 1:1 ratio (four weeks on, four weeks off) allows growth hormone receptors to reset. Extending the active phase beyond six weeks without a break leads to diminishing returns. Monitoring systemic recovery markers during the off period can indicate when receptor sensitivity has recovered. If these markers remain elevated deep into your off cycle, extending the break another two weeks before restarting may be beneficial.

For athletes managing recurring soft tissue stress, front-loading the first cycle with slightly higher dosing, then maintaining lower doses in subsequent cycles, capitalizes on initial receptor sensitivity while preventing long-term tolerance buildup. Skip this timing strategy, and you may find yourself needing higher doses for the same effect by cycle three.

Troubleshooting

When your Wolverine stack dosage isn’t delivering the tissue repair you expect, the problem usually lies in one of three areas: reconstitution errors, injection timing mismatches, or unrealistic expectations about recovery velocity. Adjusting a dosing schedule before checking whether the peptides were stored correctly is a common misstep. Before you increase your dose, verify that the protocol fundamentals are solid.

When You’re Not Seeing Recovery Progress

If you’re two weeks into your protocol and tissue pain hasn’t shifted, start by confirming your reconstitution math was accurate. A common error is using too much bacteriostatic water, which dilutes the peptide concentration below the therapeutic threshold. If you added 2 mL of water to a 5 mg vial and assumed each 0.1 mL gave you 250 mcg, you’d be underdosing by half. Recalculate using the correct formula: total peptide mass divided by total reconstitution volume gives you concentration per mL. Then multiply by your injection volume to confirm you’re hitting your target dose.

Another factor to examine is injection site rotation. Repeatedly injecting the same area can create localized tissue changes that reduce peptide absorption. If you’ve been targeting the same small zone for ten consecutive days, local tissue saturation may be blocking effective uptake. Rotate between at least four distinct sites (lower abdomen quadrants, outer thigh zones, or alternating flanks) and space injections at least one inch apart to prevent localized irritation and ensure consistent absorption.

Adjusting When Side Effects Appear

Injection site reactions (redness, swelling, or localized heat) usually mean you’re injecting too superficial or too fast. Slow your injection speed to 5–10 seconds per dose, and ensure you’re reaching subcutaneous tissue rather than intradermal layers. If reactions persist after technique correction, drop your dose by 25% for three days and monitor. Persistent inflammation at the injection site signals either a sensitivity response or contamination from non-sterile reconstitution practices.

Unusual fatigue or mood changes during a cycle can indicate that your hydration status is insufficient for the increased cellular repair activity. Peptide-driven tissue remodeling elevates your body’s demand for water and electrolytes. If you’re consuming less than half your body weight in ounces of water daily, or if you’re training in heat without electrolyte supplementation, metabolic waste products accumulate faster than your kidneys can clear them. Increase water intake to 0.6 ounces per pound of body weight, and add 400–600 mg of magnesium glycinate and 2–4 grams of sodium daily, split across meals.

When to Pivot Your Dosing Strategy

If you’ve verified reconstitution accuracy, site rotation, and injection technique, but recovery still stalls after three weeks, the issue may be dosing frequency rather than total dose. Some clients respond better to smaller, more frequent injections than to larger doses spaced further apart. Try splitting your daily dose into two injections—one in the morning, one post-training—to maintain more consistent peptide availability at the injury site.

When none of these adjustments shift your biomarkers or subjective recovery, it’s time to reassess whether the stack aligns with your injury type. Peptides excel at soft tissue repair (tendons, ligaments, muscle) but they don’t address structural issues like bone fractures or cartilage defects that require different interventions. If your injury involves significant cartilage loss or bone pathology, peptides alone won’t close the gap. In those cases, a wellness consultation can help you assess your health needs and determine whether a peptide protocol is the right fit or whether other interventions should be considered.

What to Do Next

Getting your Wolverine stack dosage right isn’t a one-and-done calculation. It’s a dynamic process that adapts to your body’s response over time. We’ve walked you through baseline assessments, injury-specific protocols, and response tracking because personalized dosing is what separates meaningful tissue repair from generic protocols that miss the mark. The next step is committing to a structured tracking system that captures your biomarker shifts and adjusts your protocol as your body heals.

Moving Forward with a Personalized Protocol

Start by scheduling a comprehensive consultation to establish your baseline inflammatory state and tissue damage profile. Our clinical team reviews your health data and clinical presentation to determine your initial peptide doses, then monitors your recovery progress through follow-up assessments. Regular check-ins allow us to recalibrate your protocol before you waste weeks on a dose that’s too conservative or too aggressive for your injury type.

Your dosing schedule should evolve with your recovery. Most clients begin with an initial loading phase, then transition to maintenance dosing or cycle off entirely once clinical improvement stabilizes. Our practitioners evaluate your response throughout the protocol to confirm that peptides are supporting tissue repair as intended. When progress plateaus, that signals it’s time to pause and let your receptors reset.

Resources for Long-Term Success

You’ll need ongoing clinical monitoring to catch desensitization before it derails your progress. We track core biomarkers (ranging from hormones to toxins to gut health) to guide adjustments without guessing. We also recommend keeping a recovery log that tracks joint pain scores, range of motion, and injection site tolerance. When you can document a clear improvement in functional movement, you have objective proof the protocol is working.

If you’re managing chronic tissue damage, expect to periodically revisit your dosing strategy. Acute injuries often resolve within a single cycle, but tendon tears or cartilage degeneration require phased protocols that shift as your tissue architecture rebuilds. Our personalized approach means your protocol is reviewed and adjusted based on your clinical response and evolving health needs, so you’re never following a static plan that assumes your body stays the same throughout recovery.

The difference between a protocol that works and one that wastes your time comes down to accountability and adaptation. Generic dosing guides can’t account for your unique physiological baseline. We build protocols tailored to your individual health profile, giving you the precision you need to rebuild tissue faster and avoid the trial-and-error cycles that most clients struggle through.

FAQ

How long does it take to see results from the Wolverine stack?

Most clients notice early pain reduction and improved range of motion within 2–3 weeks. Structural tissue repair (confirmed by biomarkers like procollagen levels or imaging) typically takes 6–8 weeks. Subjective symptom relief often precedes actual structural improvement, so tracking objective markers prevents premature protocol discontinuation.

Can I use the Wolverine stack for chronic injuries?

Yes. Chronic tendinopathy, ligament laxity, or joint inflammation can respond to TB-500 and BPC-157, but the protocol differs from acute injury dosing. Chronic cases benefit from lower-frequency injections (2–3 times weekly) with extended cycles (6–8 weeks) to support gradual tissue remodeling. Expect slower progress than acute injuries because you’re reversing months of tissue degeneration.

What’s the difference between subcutaneous and localized injection?

Subcutaneous injections deliver peptides systemically, distributing throughout your body via circulation. Localized injections place the peptide near the injury site (within 2–3 cm), which can increase local concentration and accelerate angiogenesis at the damaged tissue. Both methods work, but localized injections may provide faster site-specific repair for injuries like tendon tears or ligament sprains.

Are there any side effects I should watch for?

Common side effects include mild injection site reactions (redness, swelling), which typically resolve within 24 hours. Persistent reactions suggest injection technique issues or sensitivity. Unusual fatigue, headaches, or mood changes may indicate inadequate hydration or electrolyte imbalance during the repair phase. Serious side effects are rare but include allergic reactions or contamination from non-sterile reconstitution.

How do I know if my peptides are legitimate?

Pharmaceutical-grade peptides come with third-party testing certificates confirming purity (typically >98%) and concentration. Gray-market sources often lack these certifications and may contain underdosed or contaminated products. Request a certificate of analysis (CoA) from your supplier. If they can’t provide one, the peptides are suspect.

Can I stack other peptides with BPC-157 and TB-500?

Some clients add growth hormone secretagogues or other repair peptides to their protocols. However, stacking increases complexity and makes it harder to isolate which compound is driving results. We recommend running BPC-157 and TB-500 alone for your first cycle to establish baseline response, then considering additional compounds only if recovery plateaus.

Do I need to cycle off, or can I run the stack continuously?

Cycling off is necessary to prevent receptor desensitization. A 1:1 ratio (4 weeks on, 4 weeks off) preserves receptor sensitivity for future cycles. Running peptides continuously for longer than 6–8 weeks without a break leads to diminishing returns and higher doses needed to achieve the same effect.

What happens if I miss a dose?

Missing a single dose won’t derail your protocol, but consistent gaps reduce peptide availability during the critical repair window. If you miss a dose, resume your normal schedule at the next injection time. Don’t double up to compensate. If you’re missing doses frequently, consider switching to a lower-frequency protocol (every other day or 3x weekly) that’s easier to maintain.